ACAD — ACADIA Pharmaceuticals Inc. stock price, charts and financials

QT78ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.29
-0.16-0.58%
OverviewShort InterestFilings
ACADQT78ACADIA Pharmaceuticals Inc.·NASDAQ
27.29-0.58%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 11, 20268-KCurrent report
Aug 07, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 202610-QQuarterly report
Aug 05, 2026144Notice of proposed sale of restricted securities
Aug 04, 20268-KCurrent report
Jul 31, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 2026144Notice of proposed sale of restricted securities
Jun 10, 2026S-8Registration of employee benefit securities
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 26, 2026144Notice of proposed sale of restricted securities
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 05, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 01, 20268-KCurrent report
#1 / 25 of 347
Page
▼
/ 14